Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cellsMark Cavanagh2021-01-12T14:16:40+00:0021st April 2020|Read More
Mogrify awarded $1.1M additional funding from SBRI HealthcareMark Cavanagh2021-01-11T10:40:49+00:0028th January 2020|Read More
Mogrify wins Innovation Award and Dr. Jane Osbourn, OBE receives Lifetime Achievement Award at Scrip Awards 2019Mark Cavanagh2020-11-23T16:05:44+00:005th December 2019|Read More
Mogrify wins Seed Stage Finance Raise of the Year at 2019 European Lifestars AwardsMark Cavanagh2020-11-23T16:06:25+00:0020th November 2019|Read More
Mogrify named ‘The One to Watch’ at Cambridge Independent Science and Technology Awards 2019Mark Cavanagh2020-11-23T16:07:12+00:0031st October 2019|Read More
Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapiesMark Cavanagh2020-11-23T16:02:12+00:0014th October 2019|Read More